Medicare Enrolled
Dr. Sameer Malhotra, M.D.
Urology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Malhotra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Malhotra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Malhotra
Dr. Sameer Malhotra is an urology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Malhotra performed 3,037 Medicare services across 2,161 unique beneficiaries.
Between the years covered by Open Payments, Dr. Malhotra received a total of $7,328 from 46 pharmaceutical and/or device companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Malhotra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 27% volume in CA
$7,328 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,037
Medicare services
Top 27% in CA for urology physician
2,161
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
622 | $70 | $160 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
438 | $9 | $45 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
317 | $110 | $295 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
289 | $3 | $14 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
265 | $4 | $14 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
204 | $8 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
149 | $100 | $235 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 145 | $135 | $440 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
118 | $68 | $155 |
| Complicated insertion of bladder tube | 58 | $64 | $300 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
50 | $93 | $235 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
47 | $206 | $500 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
41 | $67 | $165 |
| Simple change of bladder tube | 41 | $42 | $205 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
34 | $141 | $435 |
| Injection, garamycin, gentamicin, up to 80 mg | 34 | $2 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $13 | $55 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
26 | $13 | $39 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
26 | $32 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $126 | $360 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
21 | $129 | $215 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
16 | $127 | $1,200 |
| Initial dilation of urethra in male using dilator | 16 | $30 | $185 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
12 | $193 | $560 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
12 | $53 | $240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
19.7% medium
79.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,328
Total received (2018-2024)
Avg $1,047/year across 7 years
Top 26% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
296
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,289 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,249
2023
$1,162
2022
$935
2021
$812
2020
$270
2019
$1,020
2018
$880
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$796
Sumitomo Pharma America, Inc.
$230
Astellas Pharma US Inc
$199
PROGENICS PHARMACEUTICALS, INC.
$145
Janssen Biotech, Inc.
$142
PROCEPT BioRobotics Corporation
$139
PFIZER INC.
$139
ABBVIE INC.
$122
Bayer Healthcare Pharmaceuticals Inc.
$98
Myriad Genetic Laboratories, Inc.
$55
UROGEN PHARMA, INC.
$51
Telix Pharmaceuticals
$30
Merck Sharp & Dohme LLC
$29
Axonics, Inc.
$26
Endo USA, Inc.
$25
Ferring Pharmaceuticals Inc.
$23
Top 3 companies account for 54.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,396
Teleflex LLC
$1,069
PFIZER INC.
$745
Janssen Biotech, Inc.
$672
Sumitomo Pharma America, Inc.
$453
ABBVIE INC.
$282
Boston Scientific Corporation
$183
Bayer Healthcare Pharmaceuticals Inc.
$174
Endo Pharmaceuticals Inc.
$159
PROGENICS PHARMACEUTICALS, INC.
$145
PROCEPT BioRobotics Corporation
$139
Axonics, Inc.
$135
Dendreon Pharmaceuticals LLC
$122
Coloplast Corp
$114
Merck Sharp & Dohme LLC
$106
AbbVie Inc.
$100
COLOPLAST CORP
$94
UROVANT SCIENCES INC
$89
Novartis Pharmaceuticals Corporation
$89
AbbVie, Inc.
$84
BOSTON SCIENTIFIC CORPORATION
$84
EDAP TECHNOMED INC
$84
Myriad Genetic Laboratories, Inc.
$73
UROGEN PHARMA, INC.
$72
Bayer HealthCare Pharmaceuticals Inc.
$67
Amgen Inc.
$63
Myovant Sciences Inc.
$49
MEDIVATION FIELD SOLUTIONS LLC
$48
Allergan Inc.
$41
AstraZeneca Pharmaceuticals LP
$39
Telix Pharmaceuticals
$30
Metuchen Pharmaceuticals
$29
Medtronic USA, Inc.
$28
Blue Earth Diagnostics Limited
$26
Endo USA, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$24
Hollister Incorporated
$24
Supernus Pharmaceuticals, Inc.
$24
ConvaTec Inc.
$23
Ferring Pharmaceuticals Inc.
$23
Rochester Medical Corporation
$21
Progenics Pharmaceuticals, Inc.
$20
Smith+Nephew, Inc.
$19
AKRIMAX PHARMACEUTICALS, LLC
$17
Mission Pharmacal Company
$12
180 Medical, Inc.
$12
Top 3 companies account for 43.8% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFINITOR · ALTIS · AQUABEAM SYSTEM · AVEED · Altis · Axonics · BOTOX · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · GREENLIGHT · GentleCath · ILLUCCIX · INTERSTIM · Isiris aStent Removal Device · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · PLUVICTO · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · RETRACE · SOLESTA · STRAVIX PL · SpeediCath · Stendra · TOVIAZ · Titan · UROLIFT · Uribel · UroLift System · VaPro Pocket · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
366
Per 100K population
3.7
County median income
$87,760
Nearest hospital
CEDAR-SINAI MARINA DEL REY HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Malhotra is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Malhotra experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Malhotra performed 622 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Malhotra receive payments from pharmaceutical companies?
Yes. Dr. Malhotra received a total of $7,328 from 46 companies across 296 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Malhotra's costs compare to other urology physicians in Los Angeles?
Dr. Malhotra's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Malhotra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Los Angeles
Browse urology physicians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology